Weyland Pharmaceuticals Division
GPTKB entity
Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:acquired |
gptkb:Gen_Tech_Labs
|
| gptkbp:ceo |
gptkb:Dr._Elizabeth_Weyland
|
| gptkbp:collaborates_with |
various universities
|
| gptkbp:employs |
5000 people
|
| gptkbp:focuses_on |
gptkb:biotechnology
|
| gptkbp:founded_in |
gptkb:2020
|
| gptkbp:has_part |
gptkb:Department
gptkb:Laboratory_Services gptkb:film_production_company gptkb:research_center customer service department finance department sales department business development team marketing department quality assurance team human resources department legal department clinical trials division environmental health and safety team regulatory affairs team strategic planning team supply chain management team sustainability team corporate communications team data analytics team biostatistics team research ethics board product management team clinical data management team clinical operations team clinical research organization clinical pharmacology team regulatory compliance team supply chain optimization team product safety team patient advocacy team medical affairs team clinical supply team pharmacovigilance team patient safety team market access team therapeutic area teams medical writing team partnerships and alliances team global health initiatives team |
| gptkbp:has_product_line |
gptkb:gene_therapy
antibiotics vaccines |
| gptkbp:headquarters |
gptkb:Los_Angeles
|
| https://www.w3.org/2000/01/rdf-schema#label |
Weyland Pharmaceuticals Division
|
| gptkbp:is_displayed_in |
gptkb:NASDAQ
|
| gptkbp:is_known_for |
innovative drug solutions
|
| gptkbp:operates_in |
gptkb:North_America
|
| gptkbp:part_of |
gptkb:Weyland_Corp
|
| gptkbp:produces |
medications
|
| gptkbp:research_focus |
gptkb:cancer_treatment
|
| gptkbp:revenue |
1 billion USD
|
| gptkbp:subsidiary |
Weyland Biotech
|
| gptkbp:bfsParent |
gptkb:Weyland_Corporation
|
| gptkbp:bfsLayer |
6
|